{"id":3227,"date":"2025-04-11T16:07:51","date_gmt":"2025-04-11T23:07:51","guid":{"rendered":"https:\/\/depts.washington.edu\/cfrtc\/?p=3227"},"modified":"2025-04-16T16:47:29","modified_gmt":"2025-04-16T23:47:29","slug":"pilot-28-manicone","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/cfrtc\/pilot-28-manicone\/","title":{"rendered":"Pilot 28 &#8211; Manicone"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; fullwidth=&#8221;on&#8221; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_fullwidth_slider admin_label=&#8221;Fullwidth Slider&#8221; module_id=&#8221;interior&#8221; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; custom_padding_tablet=&#8221;|||&#8221; custom_padding_phone=&#8221;|||&#8221; box_shadow_style=&#8221;preset6&#8243; box_shadow_blur=&#8221;10px&#8221; box_shadow_color=&#8221;rgba(0,0,0,0.1)&#8221; show_inner_shadow=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221; button_text_size__hover_enabled=&#8221;off&#8221; button_one_text_size__hover_enabled=&#8221;off&#8221; button_two_text_size__hover_enabled=&#8221;off&#8221; button_text_color__hover_enabled=&#8221;off&#8221; button_one_text_color__hover_enabled=&#8221;off&#8221; button_two_text_color__hover_enabled=&#8221;off&#8221; button_border_width__hover_enabled=&#8221;off&#8221; button_one_border_width__hover_enabled=&#8221;off&#8221; button_two_border_width__hover_enabled=&#8221;off&#8221; button_border_color__hover_enabled=&#8221;off&#8221; button_one_border_color__hover_enabled=&#8221;off&#8221; button_two_border_color__hover_enabled=&#8221;off&#8221; button_border_radius__hover_enabled=&#8221;off&#8221; button_one_border_radius__hover_enabled=&#8221;off&#8221; button_two_border_radius__hover_enabled=&#8221;off&#8221; button_letter_spacing__hover_enabled=&#8221;off&#8221; button_one_letter_spacing__hover_enabled=&#8221;off&#8221; button_two_letter_spacing__hover_enabled=&#8221;off&#8221; button_bg_color__hover_enabled=&#8221;off&#8221; button_one_bg_color__hover_enabled=&#8221;off&#8221; button_two_bg_color__hover_enabled=&#8221;off&#8221;][et_pb_slide _builder_version=&#8221;4.16&#8243; background_color=&#8221;#ffffff&#8221; background_image=&#8221;https:\/\/depts.washington.edu\/cfrtc\/wp-content\/uploads\/2014\/12\/microscope11.jpg&#8221; global_colors_info=&#8221;{}&#8221; button_text_size__hover_enabled=&#8221;off&#8221; button_one_text_size__hover_enabled=&#8221;off&#8221; button_two_text_size__hover_enabled=&#8221;off&#8221; button_text_color__hover_enabled=&#8221;off&#8221; button_one_text_color__hover_enabled=&#8221;off&#8221; button_two_text_color__hover_enabled=&#8221;off&#8221; button_border_width__hover_enabled=&#8221;off&#8221; button_one_border_width__hover_enabled=&#8221;off&#8221; button_two_border_width__hover_enabled=&#8221;off&#8221; button_border_color__hover_enabled=&#8221;off&#8221; button_one_border_color__hover_enabled=&#8221;off&#8221; button_two_border_color__hover_enabled=&#8221;off&#8221; button_border_radius__hover_enabled=&#8221;off&#8221; button_one_border_radius__hover_enabled=&#8221;off&#8221; button_two_border_radius__hover_enabled=&#8221;off&#8221; button_letter_spacing__hover_enabled=&#8221;off&#8221; button_one_letter_spacing__hover_enabled=&#8221;off&#8221; button_two_letter_spacing__hover_enabled=&#8221;off&#8221; button_bg_color__hover_enabled=&#8221;off&#8221; button_one_bg_color__hover_enabled=&#8221;off&#8221; button_two_bg_color__hover_enabled=&#8221;off&#8221; sticky_transition=&#8221;on&#8221;][\/et_pb_slide][\/et_pb_fullwidth_slider][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_row column_structure=&#8221;1_4,3_4&#8243; _builder_version=&#8221;4.16&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_sidebar area=&#8221;et_pb_widget_area_10&#8243; admin_label=&#8221;Pilots Sidebar&#8221; _builder_version=&#8221;4.27.2&#8243; global_colors_info=&#8221;{}&#8221;][\/et_pb_sidebar][\/et_pb_column][et_pb_column type=&#8221;3_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_text admin_label=&#8221;Text&#8221; _builder_version=&#8221;4.27.2&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<h2 style=\"text-align: left;\">P30 CFRTC &#8211; Pilot 28<\/p>\n<p>Identifying Novel Compounds to Polarize Macrophages toward Reparative States<\/p>\n<\/h2>\n<p>PI: <a href=\"https:\/\/iscrm.uw.edu\/faculty\/anne-manicone\/\"><strong>Anne Manicone, MD<\/strong><\/a><br \/>\nAssociate Professor, Medicine, Pulmonary and Critical Care<br \/>\n<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=%28manicone+a%5BAuthor%5D%29+AND+%28DK089507%29&amp;sort=pubdate&amp;sort_order=asc\">P30 CFRTC Publication<\/a><\/p>\n<p>Funding Period: 2024 &#8211; 2025<\/p>\n<p>Abstract: Cystic Fibrosis is a genetic disorder due to variants of the cystic fibrosis transmembrane conductance regulator (CFTR) gene and adversely affects function of the lungs, pancreas, intestines, and hepatobiliary tree. There are numerous studies highlighting the presence of chronic intestinal inflammation in CF. Intestinal inflammation may exacerbate malabsorption and nutritional status in CF, and studies suggest that gut health can impact pulmonary function. Macrophages are key orchestrators of inflammation and repair processes in the intestine, and studies implicate a pro-inflammatory macrophage phenotype in CF that may contribute to excessive tissue inflammation and injury. Macrophages can be targeted to change their activation state so that they downregulate pro-inflammatory cytokines\/chemokines, up-regulate anti-inflammatory ones, clear inflammatory debris and apoptotic cells, and promote epithelial cell proliferation. One such pathway that drives these reparative macrophage phenotypes includes IL-4\/STAT6 signaling. Over-expression of IL-4 or adoptive transfer of IL-4 stimulated macrophages attenuates TNBS-induced colitis, whereas deficiency of the IL-4 receptor alpha chain triggers early onset severe colitis in mice. These findings suggest a beneficial role for IL4\/STAT6 pathway activation in macrophages to dampen intestinal inflammation. Based on these findings, we hypothesize that identification of compounds that promote IL\u00024\/STAT6 polarization may be used as therapeutics in dampening CF-related intestinal inflammation. <\/p>\n<p>In aim 1, we will use high throughput studies to identify novel compounds that promote or enhance IL-4\/STAT6 polarization. We will generate macrophage reporter cell lines to identify reparative and pro-inflammatory polarized states. These cells will be used to screen 50,000 entity Diversity Set (Chembridge), which covers all biological spaces thought to interact with small molecules. Select hits will undergo screening for cell toxicity, dose-responses, and validation in primary human and murine macrophages. <\/p>\n<p>In aim 2, we will test novel compounds that promote IL-4\/STAT6 polarization for toxicity and therapeutic efficacy in mice. Lead candidates will undergo therapeutic testing in a murine CF model. This proposal will use innovative approaches and concepts to identify compounds that promote reparative macrophage phenotypes as novel immune-modulating therapeutics.<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pilot 20 &#8211; CF kidney phenotype and potential consequences in the era of CFTR correction<\/p>\n<p>P.I.: Edward Kelly, PhD<br \/>\nAssociate Professor, Pharmaceutics<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"<p>P.I.: <a href=\"http:\/\/depts.washington.edu\/metab\/directory\/faculty\/steven-e-kahn-m-b-ch-b\/\" target=\"_blank\">Steven Kahn, MB, ChB<\/a><br \/> Professor of Medicine<br \/> Metabolism, Endocrinology and Nutrition<\/p><p><a href=\"http:\/\/depts.washington.edu\/metab\/directory\/faculty\/kristina-utzschneider-m-d\/\" target=\"_blank\">Kristina Utzschneider, MD<\/a><br \/> Associate Professor of Medicine<br \/> Metabolism, Endocrinology and Nutrition<\/p><p>With the increased life expectancy of patients with cystic fibrosis (CF), other co-morbidities have become apparent in these patients. One of these is abnormal glucose metabolism, where CF-related diabetes (CFRD) is common. More recently, another abnormality of glucose metabolism has been recognized; namely late hypoglycemia following oral glucose loading. In this study, we propose to test the hypothesis that the post-glucose load hypoglycemia observed in patients with CF results from a deficient counterregulatory hormone response and\/or an insulin response that is exaggerated and delayed. This increased insulin response could be the result of an exaggerated incretin hormone response or altered gastric emptying. To address this hypothesis, we will perform a 3-hour oral glucose tolerance test during which we will measure counterregulatory, islet and incretin hormone responses and determine the rate of gastric emptying using acetaminophen. To determine whether patients with CF and late hypoglycemia also have episodes of hypoglycemia during daily living that includes mixed meals, we will use a continuous glucose monitoring system (CGMS) to examine 24-hour glucose profiles for 3 days. All these measures will be compared between patients with CF who develop late hypoglycemia, CF patients who do not develop hypoglycemia, and age and body mass index-matched healthy controls. The findings from this study will provide important new information regarding the mechanism(s) responsible for the late hypoglycemia observed in patients with CF and the data could be used as the basis for future grant applications. The ultimate goal is to gain insight into the condition of late hypoglycemia in order to better manage patients with CF.<\/p>","_et_gb_content_width":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[2],"tags":[],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/cfrtc\/wp-json\/wp\/v2\/posts\/3227"}],"collection":[{"href":"https:\/\/depts.washington.edu\/cfrtc\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/cfrtc\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/cfrtc\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/cfrtc\/wp-json\/wp\/v2\/comments?post=3227"}],"version-history":[{"count":9,"href":"https:\/\/depts.washington.edu\/cfrtc\/wp-json\/wp\/v2\/posts\/3227\/revisions"}],"predecessor-version":[{"id":3293,"href":"https:\/\/depts.washington.edu\/cfrtc\/wp-json\/wp\/v2\/posts\/3227\/revisions\/3293"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/cfrtc\/wp-json\/wp\/v2\/media?parent=3227"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/cfrtc\/wp-json\/wp\/v2\/categories?post=3227"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/cfrtc\/wp-json\/wp\/v2\/tags?post=3227"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}